tradingkey.logo

LakeShore Biopharma Co Ltd

LSB
0.627USD
0.000
Market hours ETQuotes delayed by 15 min
13.02MMarket Cap
--P/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H1
FY2024H2
FY2024H1
Total revenue
34.25%50.98M
--41.87M
--37.97M
Revenue
34.25%50.98M
--41.87M
--37.97M
Cost of revenue
22.17%8.86M
--9.13M
--7.26M
Operating expenses
-26.33%46.75M
--56.53M
--63.45M
R&D expenses
-62.25%9.39M
--17.28M
--24.87M
Depreciation, depletion, and amortization
25.67%3.48M
--3.10M
--2.77M
Operating profit
116.60%4.23M
---14.66M
---25.48M
Net non-operating interest income (expenses)
Non-operating interest income
----
----
--272.19K
Non-operating interest expense
-56.59%900.84K
----
--2.08M
Gains from sale of securities
----
---6.18M
----
Special income (expenses)
-95.47%43.17K
---22.28M
--952.63K
- Gains from disposal of fixed assets
---1.13M
----
----
Other non-operating income (expenses)
-62.02%741.04K
--2.30M
--1.95M
Income before tax
112.25%2.99M
---39.01M
---24.38M
Income tax
246.35%166.93K
---2.91M
---114.06K
Income after tax
111.62%2.82M
---36.10M
---24.27M
Net income from continuous operations
111.62%2.82M
---36.10M
---24.27M
Net income attributable to controlling interests
111.62%2.82M
---36.10M
---24.27M
Preferred share dividend
----
--0.00
----
Net income attributable to common shareholders
111.62%2.82M
---36.10M
---24.27M
Basic earnings per share
105.68%0.15
---2.99
---2.61
Diluted earnings per share
105.68%0.15
---2.99
---2.61
Dividend per share
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
Audit opinions
--
--
--
KeyAI